Delivery Order SPE2DB22D9239-SPE2DB24FDH53
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $109,272.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of XENPOZYME 20 MG VIALS, a specialized pharmaceutical product, with a period of performance through November 6, 2024. DMS Pharmaceutical Group is a key supplier for the DLA, holding a $499,999,999 Indefinite Delivery Contract to...
- The U.S. Defense Logistics Agency awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XENPOZYME 20 mg vials. The $109,272.60 contract has a completion date of March 19, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of branded and generic drugs to government agencies, particularly the Department of Veterans Affairs and Department of...
- The Defense Logistics Agency awarded a delivery order valued at $87,418.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xenpozyme 20 mg vials. The contract was awarded on September 4, 2025, with an ultimate completion date of September 25, 2025, and utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite...
- This federal contract award, valued at $109,272.60, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The delivery order contract is for the supply of XENPOZYME 20 MG VIALS, with a performance period through May 2, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract, contract 4600082013 under the DLA's SPE2DB program, valued at up to $4,999,999 through the end of...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on August 29, 2025, for the supply of Xenpozyme 20 mg vials. This firm fixed-price delivery order, valued at $87,418.08, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at seventy-two thousand eight hundred forty-eight dollars and thirty cents ($72,848.30) by the Defense Logistics Agency to provide forty-five hundred sixty-three thousand ten vials of XENPOZYME 20 MG. The place of performance will be Park Ridge, Illinois and all work must be completed by December 18, 2023. As a woman-owned small business, DMS Pharmaceutical Group holds an indefinite delivery contract with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $87,418.08 firm fixed-price contract is for the delivery of XENPOZYME 20 MG VIALS, with a completion date of June 11, 2025. The contract is not set aside for any specific business category. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under...
- This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a delivery order worth $87,418.08 for the supply of 4567903324 - XENPOZYME 20 MG VIALS, a specialized pharmaceutical product. The contract is a firm fixed-price arrangement with an ultimate completion date of April 23, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $253,772.90 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Xenpozyme 20 mg vials, with an ultimate completion date of October 20, 2025. This delivery order, issued on September 28, 2025, carries no set-aside designation and represents work to be performed in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois and registered in the System for Award Management...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract, valued at $109,272.60, is for the delivery of XENPOZYME 20 MG VIALS, a pharmaceutical product. The order has an ultimate completion date of March 29, 2024 and is not set aside for any specific business category. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract,...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB24FDH53Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $109,272.60 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of XENPOZYME 20 MG VIALS and has an ultimate completion date of April 15, 2024. This delivery order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract with DLA, contract 4600082013 under the SPE2DB program, which is valued at up to $4,999,999 through the end of 2025. The contract has no set-aside designation. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies, primarily the Department of Veterans Affairs and the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $109.3k | 3/25/24 |